"Prognosis" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A prediction of the probable outcome of a disease based on a individual's condition and the usual course of the disease as seen in similar situations.
| Descriptor ID |
D011379
|
| MeSH Number(s) |
E01.789
|
| Concept/Terms |
Prognostic Factors- Prognostic Factors
- Factor, Prognostic
- Factors, Prognostic
- Prognostic Factor
|
Below are MeSH descriptors whose meaning is more general than "Prognosis".
- Analytical, Diagnostic and Therapeutic Techniques and Equipment [E]
- Diagnosis [E01]
- Prognosis [E01.789]
Below are MeSH descriptors whose meaning is more specific than "Prognosis".
This graph shows the total number of publications written about "Prognosis" by people in this website by year, and whether "Prognosis" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 0 | 21 | 21 |
| 1996 | 0 | 26 | 26 |
| 1997 | 0 | 22 | 22 |
| 1998 | 0 | 30 | 30 |
| 1999 | 0 | 35 | 35 |
| 2000 | 0 | 53 | 53 |
| 2001 | 0 | 31 | 31 |
| 2002 | 0 | 26 | 26 |
| 2003 | 1 | 51 | 52 |
| 2004 | 0 | 55 | 55 |
| 2005 | 0 | 63 | 63 |
| 2006 | 0 | 46 | 46 |
| 2007 | 0 | 73 | 73 |
| 2008 | 1 | 87 | 88 |
| 2009 | 1 | 85 | 86 |
| 2010 | 0 | 89 | 89 |
| 2011 | 0 | 121 | 121 |
| 2012 | 0 | 123 | 123 |
| 2013 | 0 | 139 | 139 |
| 2014 | 1 | 119 | 120 |
| 2015 | 1 | 145 | 146 |
| 2016 | 1 | 131 | 132 |
| 2017 | 2 | 139 | 141 |
| 2018 | 4 | 144 | 148 |
| 2019 | 1 | 171 | 172 |
| 2020 | 1 | 145 | 146 |
| 2021 | 1 | 107 | 108 |
| 2022 | 0 | 49 | 49 |
| 2023 | 0 | 59 | 59 |
| 2024 | 0 | 101 | 101 |
| 2025 | 0 | 34 | 34 |
To return to the timeline,
click here.
Below are the most recent publications written about "Prognosis" by people in Profiles.
-
Characterization of chromosome 5 aberrations in TP53 mutated myeloid neoplasms with =5% blasts: An International TP53 Investigators Network (iTiN) study. Cancer. 2026 Jan 01; 132(1):e70210.
-
Pancancer outcome prediction via a unified weakly supervised deep learning model. Signal Transduct Target Ther. 2025 Sep 03; 10(1):285.
-
Accelerated epigenetic ageing worsens survival and mediates environmental stressors in fibrotic interstitial lung disease. Eur Respir J. 2025 Jun; 65(6).
-
Early Increase in Serum Transthyretin by Acoramidis Independently Predicts Improved Survival in TTR Amyloid Cardiomyopathy. J Am Coll Cardiol. 2025 May 27; 85(20):1911-1923.
-
Validation of the 5th edition of the World Health Organization and International Consensus Classification guidelines for TP53-mutated myeloid neoplasm in an independent international cohort. Blood Cancer J. 2025 May 07; 15(1):88.
-
The Landmark Series: Surgical Management of Functioning and Non-Functioning Pancreatic Neuroendocrine Tumors. Ann Surg Oncol. 2025 Jul; 32(7):4720-4728.
-
Gastric Cancer, Version 2.2025, NCCN Clinical Practice Guidelines In Oncology. J Natl Compr Canc Netw. 2025 05; 23(5):169-191.
-
Age and Saving Lives in Crisis Standards of Care: A Multicenter Cohort Study of Triage Score Prognostic Accuracy. Crit Care Explor. 2025 May 01; 7(5):e1256.
-
Noninvasive prognostication of hepatocellular carcinoma based on cell-free DNA methylation. PLoS One. 2025; 20(4):e0321736.
-
GLP-1 RA and dual GIP/GLP-1 RA treatment in MODY: a descriptive case series. BMJ Open Diabetes Res Care. 2025 Apr 23; 13(2).